Commentary on “The MLL1-H3K4me3 axis-mediated PD-L1 expression and pancreatic cancer immune evasion”

Minassian, Lori M.; Sanwalka, Daniel; Graham, Charles H.

doi:10.21037/tcr.2017.05.06

Cited by 1 publication

(1 citation statement)

References 0 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…Arginine methylation of MDH1 inhibits the malignant progression of pancreatic cancer by inhibiting glutamate metabolism (Wang et al, 2016). Moreover, one study reported that the MLL1-H3K4me3 pathway mediates pancreatic cancer immune evasion by regulating PD-L1 expression (Minassian et al, 2017). It is wellknown that mutations of KRAS and P53 play an important role in the tumorigenesis of pancreatic cancer.…”

Section: Introductionmentioning

confidence: 99%

Development of a 12-biomarkers-based prognostic model for pancreatic cancer using multi-omics integrated analysis

2020

View full text Add to dashboard Cite

Pancreatic cancer is one of the most malignant tumors of the digestive system, with insidious, rapid onset and high mortality. The 5-year survival rate is only 10%. Therefore, in-depth exploration of the potential mechanism affecting the prognosis of pancreatic cancer, and search for biomarkers that can effectively predict the prognosis of pancreatic cancer are of practical clinical importance. The mRNA sequencing data, miRNA sequencing data, methylation data and SNP data of pancreatic cancer patients available in The Cancer Genome Atlas (TCGA) were used for analysis to identify biomarkers that significantly affect the prognosis for the patients. Finally, a prognostic prediction model was developed using principal component analysis (PCA) method. The genes that significantly affected the prognosis of pancreatic cancer were as follows: 5 DmiRNAs (hsa-mir-1179, hsa-mir-1224, hsa-mir-1251, hsa-mir-129-1 and hsa-mir-129-2), 6 DmRNAsandDMsandMethyCor database entries (MAPK8IP2, CPE, DPP6, MSI1, IL20RB and S100A2), and FMN2 gene from differential expressed mRNAs and differential single-nucleotide polymorphism (DmRNAsandDSNPs) database. Prognostic index (PI)=∑iwi xi – 0.717716. A patient was predicted as high/low risk if the PI was larger/smaller than 0.034045. Our study resulted in a comprehensive prognostic model for pancreatic cancer patients based on multi-omics analysis, which could offer better guidance for the clinical management of patients with early-stage pancreatic cancer.

show abstract

Section: Introductionmentioning

confidence: 99%